Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Mar 22, 2019 (8 years ago)

Biotin 10 mg/mL Injection

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed pH Specification: product does not meet pH label claim.

Cause type: Failed specification

A physical or chemical test other than potency, dissolution, impurity or stability failed - pH, viscosity, appearance, tablet integrity, fill volume. A product outside its own specification may not perform as designed, even if the active ingredient is present. All failed specification recalls.

What was recalled

Biotin 10 mg/mL Injection, 30 mL vial, Rx only, 511 S. Harbor Blvd., Building. F, La Habra, CA 90631, 562-352-9630.

Drug: Biotin

Recalling firm
Auro Pharmacies Inc. DBA Central Drugs
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1082-2019 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Biotin recalls

See all

Other recalls by Auro Pharmacies Inc. DBA Central Drugs

All 2019 recalls
Class II · Moderate risk

Methyl-Cobalamin injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1167-2018
Class II · Moderate risk

Folic Acid injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1166-2018